67883-69-6 Usage
Uses
Used in Pharmaceutical Industry:
Tripterifordin is used as a therapeutic agent for its anti-inflammatory, anticancer, and immunosuppressive effects. Its ability to modulate the immune response and reduce inflammation makes it a promising candidate for the treatment of various diseases and conditions.
Used in Cancer Treatment:
Tripterifordin is used as an anticancer agent, particularly for its potential to inhibit the growth of cancer cells and promote apoptosis. It has been studied for its efficacy in treating various types of cancer, including solid malignancies.
Used in Immunosuppressive Therapy:
Tripterifordin is used as an immunosuppressive agent, which can help in managing autoimmune diseases and conditions that involve an overactive immune response. Its immunosuppressive properties can be beneficial in reducing inflammation and alleviating symptoms associated with these conditions.
Check Digit Verification of cas no
The CAS Registry Mumber 67883-69-6 includes 8 digits separated into 3 groups by hyphens. The first part of the number,starting from the left, has 5 digits, 6,7,8,8 and 3 respectively; the second part has 2 digits, 6 and 9 respectively.
Calculate Digit Verification of CAS Registry Number 67883-69:
(7*6)+(6*7)+(5*8)+(4*8)+(3*3)+(2*6)+(1*9)=186
186 % 10 = 6
So 67883-69-6 is a valid CAS Registry Number.
67883-69-6Relevant academic research and scientific papers
Reaction between phenols and isoprene under zeolite catalysis. Highly selective synthesis of chromans and o-isopentenylphenols
Bigi, Franca,Carloni, Silvia,Maggi, Raimondo,Muchetti, Chiara,Rastelli, Massimo,Sartori, Giovanni
, p. 301 - 304 (2007/10/03)
Chromans 3 and o-isopentenylphenols 4 are synthesized in satisfactory to good yields and selectivities by the reaction of phenols and isoprene in the presence of the commercially available acid faujasite zeolite HSZ-360.
Allylation of Quinones with Allyltin Reagents
Naruta, Yoshinori
, p. 3774 - 3783 (2007/10/02)
Lewis acid (BF3) catalyzed allylation of quinones with allyl- (2a), 2-methyl-2-propenyl- (2b), trans-2-butenyl- (2c,d), 3-methyl-2-butenyl- (2e,f), and trans-cinnamyltrialkyltin (2g) gives the corresponding allylhydroquinones with high regioselectivity.Vitamin K2(5) (7) and coenzyme Q1 (9) were prepared in yields of 78 and 75percent, respectively.These reactions appear to proceed through allylquinol intermediates which undergo rearrangement under the influence of BF3.The success of this synthesis of vitamin K2(5) and coenzyme Q1 depends on the fact that the reaction of 3-methyl-2-butenyltin with quinones occurs at the α carbon of the allylic system.
